TaiMed Biologics Inc. (TPEX:4147)

TaiMed Biologics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	21,246	23,485	20,746	17,843	17,813	21,212
Market Cap Growth	8.55%	13.20%	16.27%	0.17%	-16.02%	-15.12%
Enterprise Value	20,116	21,842	20,859	17,860	17,487	20,408
Last Close Price	77.80	86.00	80.83	69.69	69.59	82.90
Forward PE	-	-	282.76	-	-	87.60
PS Ratio	34.98	38.49	42.19	31.69	43.09	29.36
PB Ratio	5.30	5.84	8.09	6.57	6.06	6.21
P/TBV Ratio	6.09	6.74	10.69	8.96	8.40	8.57
EV/Sales Ratio	33.12	35.80	42.42	31.72	42.30	28.25
EV/EBITDA Ratio	-	-	-	-	-	8869.02
Debt / Equity Ratio	0.13	0.13	0.29	0.28	0.19	0.17
Debt / EBITDA Ratio	-	-	-	-	-	130.59
Asset Turnover	0.12	0.14	0.12	0.13	0.08	0.15
Inventory Turnover	0.36	0.28	0.20	0.27	0.27	0.29
Quick Ratio	12.82	13.26	2.31	2.32	5.12	3.23
Current Ratio	24.12	25.18	5.96	6.56	10.37	6.02
Return on Equity (ROE)	-5.15%	-6.13%	-7.38%	-9.52%	-14.82%	-5.24%
Return on Assets (ROA)	-2.98%	-3.55%	-2.60%	-2.75%	-6.20%	-1.67%
Return on Capital (ROIC)	-3.28%	-4.01%	-3.06%	-3.43%	-8.11%	-2.18%
Earnings Yield	-1.00%	-0.86%	-0.94%	-1.51%	-2.64%	-0.86%
FCF Yield	-1.75%	-1.65%	-0.15%	-3.41%	-1.24%	-1.21%
Buyback Yield / Dilution	-7.90%	-6.08%	-0.18%	-0.04%	-0.03%	-0.07%

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.